Literature DB >> 7989131

Recipient-mediated effect of a traditional Chinese herbal medicine, ren-shen-yang-rong-tang (Japanese name: ninjin-youei-to), on hematopoietic recovery following lethal irradiation and syngeneic bone marrow transplantation.

Y Fujii1, M Imamura, M Han, S Hashino, X Zhu, H Kobayashi, K Imai, M Kasai, K Sakurada, T Miyazaki.   

Abstract

Ren-shen-yang-rong-tang (Japanese name: Ninjin-youei-to, NYT), a traditional Chinese herbal medicine, was evaluated for recipient-mediated effect on hematopoietic recovery in a murine model of syngeneic bone marrow transplantation (BMT). BALB/c recipient mice were preconditioned with a lethal total body irradiation (TBI) at a dose of 6.5 Gy and transplanted with syngeneic bone marrow (BM) cells. NYT treatments, given intraperitoneally (i.p.) once per day for 3 consecutive days in a dose of 0.625 mg, were performed either before or after TBI and BMT to assess any recipient-mediated effect of this compound. NYT pretreatment was as effective as NYT posttreatment in enhancing the total number of colony-forming unit erythroid (CFU-E) and colony-forming unit granulocyte-macrophage (CFU-GM) per marrow and spleen after TBI and BMT. NYT pretreatment caused a significant increase in marrow and splenic CFU-E and CFU-GM numbers over a prolonged period following TBI and BMT, and affected late-stage erythropoiesis (CFU-E) more profoundly than early-stage erythropoiesis (burst-forming unit erythroid, BFU-E). NYT pretreatment significantly accelerate recovery of not only erythrocyte and leukocyte counts but also platelet counts after transplantation with a limited number (1 x 10(5)) of BM cells. The same treatment, however, was significantly less effective in hematopoietic recovery after transplantation with a minimal number (1 x 10(4)) of BM cells, indicating that NYT accelerates recovery of donor-derived rather than recipient-derived cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989131     DOI: 10.1016/0192-0561(94)90134-1

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  4 in total

1.  Herbal medicine Ninjinyoeito ameliorates ribavirin-induced anemia in chronic hepatitis C: a randomized controlled trial.

Authors:  Yoshiharu Motoo; Hisatsugu Mouri; Koushiro Ohtsubo; Yasushi Yamaguchi; Hiroyuki Watanabe; Norio Sawabu
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

2.  Oral Administration of Ren-Shen-Yang-Rong-Tang 'Ninjin'yoeito' Protects Against Hematotoxicity and Induces Immature Erythroid Progenitor Cells in 5-Fluorouracil-induced Anemia.

Authors:  Fumihide Takano; Yasuyuki Ohta; Tomoaki Tanaka; Kenroh Sasaki; Kyoko Kobayashi; Tomoya Takahashi; Nobuo Yahagi; Fumihiko Yoshizaki; Shinji Fushiya; Tomihisa Ohta
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-27       Impact factor: 2.629

3.  The synergistic effects of traditional Chinese herbs and radiotherapy for cancer treatment.

Authors:  Lili Jia; Shumei Ma; Xue Hou; Xin Wang; Abu Baker Layth Qased; Xuefei Sun; Nan Liang; Huicheng Li; Heqing Yi; Dejuan Kong; Xiaodong Liu; Feiyue Fan
Journal:  Oncol Lett       Date:  2013-03-12       Impact factor: 2.967

Review 4.  Kampo Medicines for Frailty in Locomotor Disease.

Authors:  Hajime Nakae; Yuko Hiroshima; Miwa Hebiguchi
Journal:  Front Nutr       Date:  2018-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.